ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
node1 |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
prov:Person |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
owl:sameAs |
https://semopenalex.org/author/A5083779031 |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
foaf:familyName |
Karimi‐shahrbabak |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
foaf:givenName |
Elahe |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |
foaf:name |
Elahe Karimi‐shahrbabak |
ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial |
dcterms:creator |
ripekg:author/RIPEAUA390A0CF0C25818AElahe Karimi‐shahrbabak |